Top Published Expert Doctors for Diabetic Nephropathies
756 top medical experts on Diabetic Nephropathies across 62 countries and 41 U.S. states, including 677 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Diabetic Nephropathies: kidney injuries associated with diabetes mellitus and affecting kidney glomerulus; arterioles; kidney tubules; and the interstitium. Clinical signs include persistent proteinuria, from microalbuminuria progressing to albuminuria of greater than 300 mg/24 h, leading to reduced glomerular filtration rate and END-stage renal disease.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Kidney Diseases (3,539), Diabetes Complications (4,287).
  4. Clinical Trials ClinicalTrials.gov : at least 385 including 13 Active, 212 Completed, 51 Recruiting
  5. Synonyms: Diabetic Glomerulosclerosis,  Diabetic Glomerulosclerosis


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Heerspink, Hiddo J Lambers   Google Publications
    Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands .
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Renal Insufficiency, Chronic; Albuminuria; Benzhydryl Compounds
    Categories: Therapeutic Use; Drug Therapy; Prevention & Control; Complications; Drug Effects; Administration & Dosage

  2. de, Zeeuw Dick   Google Publications
    Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency, Chronic; Cardiovascular Diseases; Kidney Failure, Chronic
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Complications; Metabolism; Blood

  3. Perkovic, Vlado   Google Publications
    The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Albuminuria; Sodium-Glucose Transporter 2 Inhibitors; Hypoglycemic Agents
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Complications; Etiology; Administration & Dosage

  4. Agarwal, Rajiv   Nephrology   Google Publications
    Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN, USA.
    Physician  Highly Cited  Clinical Trial 
    Disclosed payments in 2021 from 54 biomedical companies, totalling $105,037.04, including $80,747.33 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Albuminuria; Cardiovascular Diseases; Kidney Failure, Chronic
    Categories: Drug Therapy; Therapeutic Use; Metabolism; Complications; Prevention & Control; Administration & Dosage

  5. Charytan, David M   Nephrology   Google Publications
    Nephrology Division, New York University School of Medicine and New York University Langone Medical Center, New York, New York. Top Hospital
    Physician  Highly Cited  Clinical Trial  Review 
    Medical school: New York University School of Medicine (MD, 1998)
    Medicare Accepted
    Disclosed payments in 2021 from 8 biomedical companies, totalling $11,988.4, including $3,520 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, Chronic
    Categories: Prevention & Control; Therapeutic Use; Drug Therapy; Diet Therapy; Drug Effects; Mortality

  6. Bakris, George L   Google Publications
    University of Chicago IL. Top Hospital
    Scientist  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency, Chronic; Atrasentan; Kidney Failure, Chronic
    Categories: Drug Therapy; Therapeutic Use; Complications; Prevention & Control; Administration & Dosage; Blood

  7. Wheeler, David C   Google Publications
    Department of Renal Medicine, University College London, United Kingdom.
    Scientist  Highly Cited  Clinical Trial  Review 
    Subjects: Sodium-Glucose Transporter 2 Inhibitors; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Benzhydryl Compounds; Cardiovascular Diseases
    Categories: Therapeutic Use; Drug Therapy; Prevention & Control; Complications; Epidemiology; Therapy

  8. Bhatt, Deepak L   Interventional Cardiology  Google Publications
    Brigham and Womens Hospital Heart and Vascular Center Harvard Medical School Boston MA. Top Hospital
    Physician  Highly Cited  Clinical Trial  Review 
    Medical school: Js Weill Medical College, Cornell University (MD, 1993)
    Medicare Accepted
    Disclosed payments in 2021 from 32 biomedical companies, totalling $169,114.48, including $51,540 from  PFIZER INC.
    Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Cardiovascular Diseases; Adamantane; Dipeptides
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Administration & Dosage; Analogs & Derivatives; Epidemiology

  9. Rossing, Peter     ClinicalTrials.gov Google Publications
    Steno Diabetes Center Copenhagen, Gentofte, Denmark.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Albuminuria; Cardiovascular Diseases; Kidney Failure, Chronic
    Categories: Blood; Urine; Drug Therapy; Therapeutic Use; Complications; Genetics

  10. Tuttle, Katherine R   Nephrology   ClinicalTrials.gov Google Publications
    Division of Nephrology, Department of Medicine, University of Washington, & Providence Health Care, Spokane, Washington. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: Other (MD, 2007)
    Disclosed payments in 2021 from 23 biomedical companies, totalling $48,229.77, including $15,640 from  Novo Nordisk AS
    Subjects: Diabetes Mellitus, Type 2; Kidney Failure, Chronic; Hypoglycemic Agents; Kidney; Renal Insufficiency, Chronic
    Categories: Drug Therapy; Therapeutic Use; Drug Effects; Metabolism; Mortality; Blood

  11. Jardine, Meg J   Google Publications
    The George Institute for Global Health, UNSW, Sydney, Australia.
    Scientist  Highly Cited  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, Chronic; Albuminuria
    Categories: Therapeutic Use; Prevention & Control; Drug Therapy; Etiology; Epidemiology; Complications

  12. Pollock, Carol A   Google Publications
    Renal Research Laboratory, Kolling Institute of Medical Research, University of Sydney, Sydney, NSW 2065, Australia.
    Scientist  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Mellitus, Experimental; Kidney Tubules, Proximal; Intermediate-Conductance Calcium-Activated Potassium Channels; Kidney; Albuminuria
    Categories: Metabolism; Drug Therapy; Therapeutic Use; Genetics; Pathology; Pharmacology

  13. Neal, Bruce  Google Publications
    The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
    Scientist  Highly Cited  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, Chronic; Renal Insufficiency, Chronic
    Categories: Drug Therapy; Prevention & Control; Therapeutic Use; Metabolism; Blood; Administration & Dosage

  14. Nelson, Robert G   Internal Medicine   ClinicalTrials.gov Google Publications
    Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Kidney Failure, Chronic; Diabetes Mellitus, Type 1; Indians, North American; Kidney
    Categories: Genetics; Metabolism; Blood; Pathology; Physiopathology; Complications

  15. Levin, Adeera   Google Publications
    Division of Nephrology, University of British Columbia, Vancouver, BC, Canada A.L..
    Scientist  Highly Cited  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Canagliflozin; Kidney Failure, Chronic
    Categories: Therapeutic Use; Drug Therapy; Prevention & Control; Complications; Diet Therapy; Drug Effects

  16. Kretzler, Matthias   Nephrology   Google Publications
    Division of Nephrology, University of Michigan, Ann Arbor, MI.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: Other (MD, 1992)
    Medicare Accepted
    Disclosed payments in 2021 from 3 biomedical companies, totalling $7,150, including $4,470 from  Gilead Sciences, Inc.
    Subjects: Diabetes Mellitus, Type 2; Podocytes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Experimental; Albuminuria
    Categories: Metabolism; Genetics; Physiology; Blood; Pathology; Complications

  17. Leiter, Lawrence A     Google Publications
    Li Ka Shing Knowledge Institute, St Michaels Hospital, University of Toronto, Toronto, ON, Canada.
    Physician  Highly Cited  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Hypoglycemic Agents; Renal Insufficiency; Sodium-Glucose Transporter 2 Inhibitors
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Epidemiology; Administration & Dosage; Analogs & Derivatives

  18. Cooper, Mark E   ClinicalTrials.gov Google Publications
    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.
    Scientist  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Kidney; Albuminuria; Diabetes Mellitus, Experimental; Renal Insufficiency, Chronic
    Categories: Metabolism; Drug Therapy; Therapeutic Use; Prevention & Control; Complications; Genetics

  19. Mosenzon, Ofri   Google Publications
    Diabetes Unit and Endocrine Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
    Scientist  Highly Cited  Clinical Trial  Review 
    Subjects: Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Cardiovascular Diseases; Renal Insufficiency; Adamantane
    Categories: Drug Therapy; Therapeutic Use; Prevention & Control; Administration & Dosage; Analogs & Derivatives; Complications

  20. Wanner, Christoph     Google Publications
    Medizinische Klinik und Poliklinik 1, Schwerpunkt Nephrologie, Universitätsklinik Würzburg, Würzburg, Germany.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Mellitus, Type 2; Cardiovascular Diseases; Renal Insufficiency, Chronic; Kidney Failure, Chronic; Benzhydryl Compounds
    Categories: Therapeutic Use; Drug Therapy; Therapy; Blood; Mortality; Complications

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);